Ultrapar Participacoes
UGP
5.10
-0.12
-2.30%
Ultrapar Participacoes
US · UGP
#1675 by market cap
Listed 1970
5.10
-0.12
-2.30%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Company notice
TELA Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EW Healthcare Partners Fund 2-UGP, LLC(10.44%),EW Healthcare Partners Fund 2-GP, L.P.(10.44%), etc.SEC · 2024/10/29
-
Rating change
Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Announces Target Price $5.4Market Newswire · 2026/2/5
-
BofA Securities Maintains Ultrapar Participacoes(UGP.US) With Buy RatingMarket Newswire · 2026/11/12
-
Rating change
Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $4.1Market Newswire · 2025/1/17
-
Rating change
HSBC Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Announces Target Price $3.7Market Newswire · 2025/1/17
-
Company notice
Root Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ribbit Capital GP IV, L.P. (“GP IV”)(15.3%),Ribbit Capital GP IV, Ltd. (“UGP IV”)(15.3%), etc.SEC · 2024/11/14
-
J.P. Morgan Initiates Ultrapar Participacoes(UGP.US) With Hold RatingMarket Newswire · 2026/10/23
-
Rating change
TR | OpenAI - 4o Maintains Ultrapar Participacoes(UGP.US) With Buy Rating, Maintains Target Price $3.5Market Newswire · 2025/8/10
-
Company notice
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Chicago Pacific Founders UGP III, LLC(46.88%),Chicago Pacific Founders GP III, L.P.(46.88%), etc.SEC · 2024/11/9
-
Rating change
Goldman Sachs Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Cuts Target Price to $3.2Market Newswire · 2025/1/31
-
HSBC Downgrades Ultrapar Participacoes(UGP.US) to Hold Rating, Raises Target Price to $6Market Newswire · 2026/4/8
-
Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $6.5Market Newswire · 2026/7/1
-
Goldman Sachs Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Raises Target Price to $7.3Market Newswire · 2026/5/12
-
Rating change
Goldman Sachs Downgrades Ultrapar Participacoes(UGP.US) to Hold RatingMarket Newswire · 2026/2/5
-
Company notice
TELA Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-EW Healthcare Partners Fund 2-UGP, LLC(16.79%),EW Healthcare Partners Fund 2 GP, L.P.(16.79%), etc.SEC · 2024/2/14
-
Company notice
N-able | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Thoma Bravo UGP, LLC(27.0%),Thoma Bravo Partners XI, L.P.(18.7%), etc.SEC · 2024/11/13
-
Rating change
Banco Santander Upgrades Ultrapar Participacoes(UGP.US) to Buy Rating, Raises Target Price to $4Market Newswire · 2025/8/14
-
Rating change
BofA Securities Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Raises Target Price to $3.7Market Newswire · 2025/5/6
-
Rating change
BofA Securities Maintains Ultrapar Participacoes(UGP.US) With Hold Rating, Cuts Target Price to $3.5Market Newswire · 2025/2/7
-
Rating change
J.P. Morgan Initiates Ultrapar Participacoes(UGP.US) With Buy RatingMarket Newswire · 2025/1/8
-
Ultrapar Participacoes SA (UGP) Q4 2025 Earnings Call Highlights: Record Operational Cash Flow ...Yahoo Finance · 2026/3/10
-
Ultrapar Participações S.A. (UGP): A Bull Case TheoryYahoo Finance · 2026/3/1
-
Earnings Call Summary | Ultrapar Participacoes(UGP.US) Q4 2025 Earnings ConferenceMarket Newswire · 2026/3/6
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.
Ultrapar Participacoes discussion 0 comments